Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Pre-treatment PET scans

Paolo Strati • 3 Jul 2019
ASCO 2019
Lymphoma

Here, Paolo Strati, MD, of the University of Texas MD Anderson Cancer Center, Houston, TX, discusses the benefits of pre-treatment PET scans to identify areas of risk for transformation to large B-cell lymphomas and the significance of baseline maximum standardized uptake values (SUVmax). This interview was recorded at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

More from Paolo Strati

2:48
BTK inhibitors in the treatment of DLBCL: trials investigating these agents
Paolo Strati • 10 Dec 2023
2:14
Updates on the Smart Stop trial: the potential for a chemo-free regimen in the frontline for DLBCL
Paolo Strati • 10 Dec 2023
1:36
Loncastuximab tesirine as a consolidation strategy post-CAR T-cell therapy in DLBCL
Paolo Strati • 10 Dec 2023
1:55
Autologous SIRPα- low macrophages (SIRPant-M) enhance immune anti-tumor activity in R/R NHL
Paolo Strati • 10 Dec 2023

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals